Wendell David Associates Inc Gilead Sciences, Inc. Transaction History

Wendell David Associates Inc

$1 Billion
Q1 2025

A detailed history of Wendell David Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wendell David Associates Inc holds 13,440 shares of GILD stock, worth $1.38 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

13,440

Previous 13,640 1.47%

Holding current value

$1.38 Million

Previous $1.26 Million 19.52%

% of portfolio

0.15%

Previous 0.12%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$89.14 - $117.41 $17,828 - $23,482	-200 Reduced 1.47%	13,440 $1.51 Million
Q3 2024 Oct 21, 2024	SELL	$66.59 - $83.99 $54,603 - $68,871	-820 Reduced 5.67%	13,640 $1.14 Million
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $9,158 - $10,386	-125 Reduced 0.86%	14,460 $1.17 Million
Q3 2023 Oct 20, 2023	BUY	$73.94 - $80.67 $36,970 - $40,335	500 Added 3.55%	14,585 $1.09 Million
Q2 2023 Jul 20, 2023	SELL	$76.01 - $86.7 $3,800 - $4,335	-50 Reduced 0.35%	14,085 $1.09 Million
Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $5,954 - $6,801	-100 Reduced 0.7%	14,135 $872,000
Q2 2022 Jul 14, 2022	SELL	$57.72 - $65.01 $43,290 - $48,757	-750 Reduced 5.01%	14,235 $880,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $22,214 - $24,272	-350 Reduced 2.28%	14,985 $1.03 Million
Q1 2021 Apr 20, 2021	SELL	$60.0 - $68.46 $42,000 - $47,921	-700 Reduced 4.37%	15,335 $991,000
Q4 2020 Jan 22, 2021	SELL	$56.65 - $64.55 $2,832 - $3,227	-50 Reduced 0.31%	16,035 $934,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $7,828 - $10,027	-125 Reduced 0.77%	16,085 $1.2 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $215,670 - $237,230	-3,500 Reduced 17.76%	16,210 $1.05 Million
Q3 2019 Oct 22, 2019	SELL	$62.51 - $69.0 $21,878 - $24,150	-350 Reduced 1.74%	19,710 $1.25 Million
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $69,541 - $77,983	-1,124 Reduced 5.31%	20,060 $1.36 Million
Q1 2019 Apr 11, 2019	SELL	$62.53 - $70.05 $57,340 - $64,235	-917 Reduced 4.15%	21,184 $1.38 Million
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $110,485 - $144,175	-1,825 Reduced 7.63%	22,101 $1.38 Million
Q3 2018 Oct 12, 2018	SELL	$71.28 - $78.92 $344,282 - $381,183	-4,830 Reduced 16.8%	23,926 $1.85 Million
Q2 2018 Jul 16, 2018	SELL	$64.88 - $75.68 $198,662 - $231,732	-3,062 Reduced 9.62%	28,756 $2.04 Million
Q1 2018 Apr 11, 2018	SELL	$72.84 - $88.8 $244,014 - $297,480	-3,350 Reduced 9.53%	31,818 $2.4 Million
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $229,458 - $269,352	-3,225 Reduced 8.4%	35,168 $2.52 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.77 Million - $3.28 Million	38,393	38,393 $3.11 Million

Others Institutions Holding GILD

# of Institutions

2,172

Shares Held

991M

Call Options Held

8.71M

Put Options Held

9.4M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $129B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Gilead Sciences, Inc. Transaction History